Sanorin Nasal drops 0.1%, 10 ml
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Drops
Manufacturer country
Czech
Package quantity, pcs
one
Release form
Oral drops
pharmachologic effect
The natural physiological microflora of the intestine can be significantly disturbed by such external influences as antibiotic therapy, radiation, stomach surgery, as well as due to inappropriate or unusual nutrition, water changes, climate change and other conditions.
Hilak forte regulates the balance of intestinal microflora and normalizes its composition.
Due to the content of metabolic products of normal microflora in the composition of Hilak Forte, the drug helps to restore normal intestinal microflora in a biological way and allows you to preserve the physiological and biological functions of the intestinal mucosa.
The biosynthetic lactic acid and its buffer salts included in Hilak forte restore the normal value of acidity in the gastrointestinal tract, regardless of whether the patient suffers from high or low acidity.
Against the background of the acceleration of the development of normal intestinal symbionts under the influence of Khilak forte, the natural synthesis of vitamins of the B and K groups is normalized. balance in the intestinal lumen.
There is evidence that Hilak forte enhances the protective functions of the body by stimulating the immune response.
When using Khilak forte, there is an acceleration of the elimination of Salmonella in infants after Salmonella enteritis, which is due to the stimulation of the growth of acidophilic anaerobic intestinal flora and its subsequent antagonistic effect on Salmonella.
Indications
Violation of the physiological flora of the small and large intestine (during and after treatment with antibiotics or sulfonamides, radiation therapy)
digestive insufficiency syndrome, dyspepsia
diarrhea, flatulence, constipation
gastroenteritis, colitis
senile bowel syndrome (chronic, atrophic gastroenteritis)
disorders of the gastrointestinal tract caused by climate change
hypo- and anacid conditions
enterogenic diseases of the gallbladder and liver
allergic skin diseases (urticaria, endogenously caused chronic eczema)
salmonellosis in the stage of convalescence (including infants).
Contraindications
Hypersensitivity to drug components.
Application during pregnancy and lactation
The use of the drug Hilak forte during pregnancy and lactation is considered safe.
However, the decision on the appointment of the drug is made by the attending physician.
special instructions
Concomitant use of this drug with milk and dairy products is not recommended.
Structure
100 ml of the preparation (unflavored / cherry-flavored) contains: active ingredients:
Water substrate of metabolic products
Escherichia coli DSM 4087 * 24.9481 / 24.9481 g
Water substrate of metabolic products
Enterococcus faecalis DSM 4086 * 12.4741 / 12.4741 g
Water substrate of metabolic products
Lactobacillus acidophilus DSM 4149 * 12.4741 / 12.4741 g
Water substrate of metabolic products
Lactobacillus helveticus DSM 4183 * 49.8960 / 49.8960 g
* - substrates contain lactose
excipients: disodium phosphate heptahydrate 1.1590 / 1.1590 g, dipotassium phosphate 1.2650 / 1.2650 g, lactic acid 2.5000-6.2500 / 2.5000-6.2500 g, concentrated phosphoric acid 0 , 3520 / 0.3520 g, potassium sorbate 0.1114 / 0.114 / g, citric acid monohydrate 0.0322 / 0.0322 g, sodium saccharinate - / 0.0200 g, sodium cyclamate - / 0.2000 g, cream flavor - / 0.2000 g, cherry flavor - / 0.5000 g, water up to 100 ml.
Method of administration and dosage
Hilak forte is taken orally before or during a meal, diluted with a small amount of liquid (excluding milk).
The drug is prescribed 3 times a day:
adults: 40-60 drops per appointment
children: 20-40 drops per appointment
babies: 15-30 drops per appointment.
After improvement of the condition, the daily dose can be reduced by half.
Side effects
Hilak forte is well tolerated by patients of any age.
No side effects have been observed to date.
Allergic reactions are possible (skin rash, itching, hives)
constipation, diarrhea.
Drug interactions
Under the influence of antacid drugs, it is possible to neutralize lactic acid, which is part of the Hilak forte drug.
Storage conditions
At a temperature not higher than 25 ° C.
Keep out of the reach of children!
Shelf life
4 years.
After opening the bottle - 6 weeks.
Do not use after the expiration date indicated on the package!
Name ENG
HYLAK FORTE
Clinical and pharmacological group
A drug that regulates the balance of intestinal microflora
ATX code
Antidiarrheal drugs of biological origin, regulating the balance of intestinal microflora
Dosage
etc.
x 100ml
Structure
100 ml of the preparation (unflavored / cherry flavor) contains: active ingredients: Aqueous substrate of metabolic products Escherichia coli DSM 4087 * 24.9481 / 24.9481 g Aqueous substrate of metabolic products Enterococcus faecalis DSM 4086 * 12.4741 / 12.4741 g Water substrate of metabolic products Lactobacillus acidophilus DSM 4149 * 12.4741 / 12.4741 g Water substrate of metabolic products Lactobacillus helveticus DSM 4183 * 49.8960 / 49.8960 g * - substrates contain lactose. auxiliary substances: disodium phosphate heptahydrate 1.1590 / 1.1590 g, dipotassium phosphate 1.2650 / 1.2650 g, lactic acid 2.5000-6.2500 / 2.5000-6.2500 g, phosphoric acid, concentrated 0.3520 / 0.3520 g, potassium sorbate 0.114 / 0.114 / g, citric acid monohydrate 0.0322 / 0.0322 g, sodium saccharinate - / 0.0200 g, sodium cyclamate - / 0.2000 g, cream flavor - / 0.2000 g,cherry flavor - / 0.5000 g, water up to 100 ml.
Indications
violations of the physiological flora of the intestine (during and after treatment with antibiotics, sulfonamides, radiation therapy)
digestive insufficiency syndrome, dyspepsia
diarrhea, flatulence, constipation
gastroenteritis, colitis
senile bowel syndrome (chronic, atrophic gastroenteritis)
disorders of the gastrointestinal tract caused by climate change
hypo- and anacid conditions
enterogenic diseases of the gallbladder and liver
allergic skin diseases (urticaria, endogenously caused chronic eczema)
salmonellosis in the stage of convalescence (including in infants)
Contraindications
Hypersensitivity to drug components
INN / Active ingredient
An embryonic aqueous substrate of metabolic products Streptococcus faevalis DSM 4086 + an embryonic aqueous substrate of metabolic products Lactobacillus acidophilus DSM 4149 + an embryonic aqueous substrate of metabolic products Esherichia coli DSM 4087 + helical non-embryonic aqueous substrate of metabolic products Lveact318
Storage conditions and periods
At a temperature not higher than 25 degrees.
Shelf life: 4 years - vials (6 weeks after opening)
3 years - sachet
Specifications
Scope of the medicinal product
Gastrointestinal tract
Release form
Drops
Manufacturer country
Germany
Package quantity, pcs
one
Scope of application
Gastroenterology
,
Allergology
Minimum age from
From birth
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Shelf life after opening
6 weeks
Volume, ml.
100 ml
Brand name
Hilak forte
The amount of the dosage form in the primary package
100 ml
Primary packaging type
Dark glass bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antidiarrheal agent
Anatomical and therapeutic characteristics
A07FA Antidiarrheal microorganisms
Dosage form
Drops for oral administration
Expiration date in days
1461
The target audience
Adult
Package weight, g
one hundred
Category
:
Preparations for the gastrointestinal tract
,
Dysbacteriosis
,
Probiotics and prebiotics
,
Inulins
Mode of application
:
for adults, the drug is prescribed 40-60 drops 3 times / day < br> children - 20-40 drops 3 times / day < br> infants - 15-30 drops 3 times / day. < br> After improvement of the condition, the initial the daily dose of Hilak forte can be reduced by half. < br> The drug is taken orally before or during meals, diluted in a small amount of liquid, excluding milk.
Dosage (volume) of the substance in the preparation
: https://translate.google.com/translate?hl=&sl=ru&tl=en&u=https://zz.buy-pharm.com/xzecq.html;Description
Sanorin drops called.
0.1% fl.
10ml
Name ENG
SANORIN
Clinical and pharmacological group
A vasoconstrictor drug for local use in ENT practice
ATX code
Naphazoline
Dosage
0.1% x 10ml
Structure
1 ml contains: Active ingredient: naphazoline nitrate 1 mg
Excipients: boric acid, ethylenediamine, methyl parahydroxybenzoate, water.
Storage conditions and periods
In a dark place at a temperature of 10-25 degrees.
Expiration date: 3 years
after opening - 4 weeks
INN / Active ingredient
Naphazoline
Specifications
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Drops
Manufacturer country
Czech
Package quantity, pcs
one
Scope of application
Otorhinolaryngology
Minimum age from
2 years old
Way of introduction
Through the respiratory tract
Vacation conditions
Without recipe
Brand name
Teva
The amount of the dosage form in the primary package
10 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Decongestant - alpha adrenergic agonist
Anatomical and therapeutic characteristics
R01AA08 Naphazoline
Dosage form
Nasal drops
Packaging
Box
Dosage (volume) of the substance in the preparation
naphazoline nitrate 1 mg
The target audience
Adult
Expiration date in days
1461
Package weight, g
2
Mode of application
:
In acute rhinitis, sinusitis, eustachitis, laryngitis, to facilitate rhinoscopy Children over 2 years old - 1-2 drops of 0.05% nasal drops in each nasal passage 2-3 times a day with an interval of at least 4 hours. The course of treatment is short-term, until the symptoms of nasal congestion disappear, but not more than 1 week in adults and 3 days in children.
Re-use of the drug is possible after a few days.
In case of nosebleeds, a cotton swab moistened with 0.05% Sanorin solution can be placed in the nasal passage.
As an additional agent in the treatment of conjunctivitis of bacterial origin, nasal drops 0.05% are instilled into the conjunctival sac, 1-2 drops 3-4 times a day.
"